AMGA presents Medical Group Preeminence Award to VMMC Today presented the Medical Group Preeminence Award to Virginia Mason INFIRMARY The American Medical Group Association, a ongoing health system based in Seattle, WA. The presentation occurred at the AMGA 2012 Annual Meeting, being held March 8-10 at the Manchester Grand Hyatt levitra precio . The AMGA Medical Group Preeminence Award can be presented to physician-administrator leadership teams from AMGA member medical organizations for exceptional leadership; innovation and vision; contributions to the advancement of quality; effective healthcare delivery practices and framework; and outstanding contributions to the local public community where the healthcare organization is located.
‘International expansion is one of four key regions of opportunity for Feraheme/Rienso, and Swiss authorization marks continued progress upon this front,’ said William Heiden, president and chief executive officer of AMAG. ‘Through Takeda’s commercial efforts, Feraheme/Rienso will soon be available to CKD patients in a number of countries around the world as a new treatment option for their iron deficiency anemia. We think that these international launches, coupled with continued market penetration in the United States, the potential for a broad IDA label and overall IV iron market expansion, provide multiple avenues of growth for Feraheme.’.. AMAG receives Swiss advertising authorization for ferumoxytol to take care of iron deficiency anemia AMAG Pharmaceuticals, Inc.